Brief: Dermapharm Holding Buys Equity Investment In Corat Therapeutics GmbH
July 7 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE :
* ACQUIRES EQUITY INVESTMENT IN CORAT THERAPEUTICS GMBH
* ACQUIRES 24.9% OF SHARES IN COMPANY, WHICH IS DEVELOPING
AN
ANTIBODY DRUG FOR TREATING COVID-19
* PARTIES HAVE AGREED TO KEEP PURCHASE PRICE FOR SHARES
CONFIDENTIAL
Source text for Eikon: ID:nEQ9DMjxta
Further company coverage: DMPG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Dermapharm Holding SE
See all newsBrief: Dermapharm Confirms 2026 Forecast
Corrected: Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Brief: Dermapharm Holding - Confirms Full-Year Guidance For 2026
Brief: Dermapharm Spokesperson - Dermapharm Is Engaged In A Constructive Dialogue With The Regulator
Refile: BUZZ-Dermapharm Holding slips after BaFin's audit